Anke Van der Perren

3.4k total citations · 2 hit papers
30 papers, 2.3k citations indexed

About

Anke Van der Perren is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Anke Van der Perren has authored 30 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Anke Van der Perren's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Nerve injury and regeneration (10 papers) and Neurological disorders and treatments (7 papers). Anke Van der Perren is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Nerve injury and regeneration (10 papers) and Neurological disorders and treatments (7 papers). Anke Van der Perren collaborates with scholars based in Belgium, France and United States. Anke Van der Perren's co-authors include Veerle Baekelandt, Chris Van den Haute, Géraldine Gelders, Ronald Melki, Luc Bousset, Wouter Peelaerts, Anastasiya Moskalyuk, Michèle Giugliano, Rocco Pulizzi and Zeger Debyser and has published in prestigious journals such as Nature, Brain and Scientific Reports.

In The Last Decade

Anke Van der Perren

30 papers receiving 2.3k citations

Hit Papers

α-Synuclein strains cause distinct synucleinopathies afte... 2015 2026 2018 2022 2015 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
    2015 877 citations Wouter Peelaerts, Luc Bousset et al. Nature profile →
  2. Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease
    2018 347 citations Géraldine Gelders, Veerle Baekelandt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anke Van der Perren Belgium 17 1.5k 823 695 642 596 30 2.3k
Jennifer A. Steiner United States 21 2.0k 1.3× 1.1k 1.3× 895 1.3× 881 1.4× 746 1.3× 34 3.0k
Kathleen A. Maguire‐Zeiss United States 26 1.6k 1.0× 1.1k 1.3× 634 0.9× 1.0k 1.6× 957 1.6× 60 3.0k
Annick Prigent France 13 1.3k 0.8× 905 1.1× 464 0.7× 601 0.9× 1.0k 1.7× 17 2.6k
Ayşe Ulusoy Germany 22 1.4k 0.9× 808 1.0× 415 0.6× 625 1.0× 351 0.6× 36 2.0k
Ashley S. Harms United States 24 1.3k 0.9× 857 1.0× 657 0.9× 764 1.2× 1.5k 2.5× 36 2.8k
Valerie Joers United States 18 811 0.5× 590 0.7× 322 0.5× 657 1.0× 571 1.0× 27 1.9k
James B. Koprich Canada 33 1.9k 1.2× 1.6k 2.0× 537 0.8× 820 1.3× 545 0.9× 63 3.2k
Etty Cortés United States 25 1.4k 0.9× 1.0k 1.2× 608 0.9× 789 1.2× 314 0.5× 51 2.5k
Henrik Wilms Germany 25 1.1k 0.7× 807 1.0× 299 0.4× 614 1.0× 852 1.4× 40 2.6k
Svetlana Vidensky United States 16 947 0.6× 1.3k 1.5× 434 0.6× 1.5k 2.4× 581 1.0× 18 3.2k

Countries citing papers authored by Anke Van der Perren

Since Specialization
Citations

This map shows the geographic impact of Anke Van der Perren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Van der Perren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Van der Perren more than expected).

Fields of papers citing papers by Anke Van der Perren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Van der Perren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Van der Perren. The network helps show where Anke Van der Perren may publish in the future.

Co-authorship network of co-authors of Anke Van der Perren

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Van der Perren. A scholar is included among the top collaborators of Anke Van der Perren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Van der Perren. Anke Van der Perren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perren, Anke Van der, Audrey Coens, Géraldine Gelders, et al.. (2022). Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy. Brain. 146(1). 237–251. 13 indexed citations
2.
Perren, Anke Van der, Géraldine Gelders, Javier María Peralta Ramos, et al.. (2021). LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo. Neurotherapeutics. 18(2). 949–961. 12 indexed citations
3.
Szegő, Éva M., et al.. (2021). Rab7 reduces α-synuclein toxicity in rats and primary neurons. Experimental Neurology. 347. 113900–113900. 14 indexed citations
4.
Perren, Anke Van der, Géraldine Gelders, Alexis Fenyi, et al.. (2020). The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathologica. 139(6). 977–1000. 171 indexed citations
5.
Ramos, Javier María Peralta, Pablo Iribarren, Luc Bousset, et al.. (2019). Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration. Frontiers in Immunology. 10. 80–80. 44 indexed citations
6.
Crabbé, Melissa, Anke Van der Perren, Ilse Bollaerts, et al.. (2019). Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease. Frontiers in Neuroscience. 13. 799–799. 39 indexed citations
7.
8.
Crabbé, Melissa, Anke Van der Perren, Guy Bormans, et al.. (2019). Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy. Experimental Neurology. 320. 112964–112964. 13 indexed citations
9.
Crabbé, Melissa, Anke Van der Perren, Akila Weerasekera, et al.. (2017). Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia. Neurobiology of Aging. 61. 82–92. 31 indexed citations
10.
Perren, Anke Van der, Cindy Casteels, Koen Van Laere, et al.. (2016). Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector. Journal of Visualized Experiments. 53670–53670. 9 indexed citations
11.
Peelaerts, Wouter, Luc Bousset, Anke Van der Perren, et al.. (2015). α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 522(7556). 340–344. 877 indexed citations breakdown →
12.
Nys, Julie, Tjing‐Tjing Hu, Anke Van der Perren, et al.. (2015). Binocular pattern deprivation interferes with the expression of proteins involved in primary visual cortex maturation in the cat. Molecular Brain. 8(1). 48–48. 6 indexed citations
13.
Bentea, Eduard, Anke Van der Perren, Joeri Van Liefferinge, et al.. (2015). Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein. Frontiers in Behavioral Neuroscience. 9. 68–68. 43 indexed citations
14.
Perren, Anke Van der, Jaan Toelen, Cindy Casteels, et al.. (2014). Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors. Neurobiology of Aging. 36(3). 1543–1558. 85 indexed citations
15.
Perren, Anke Van der, Chris Van den Haute, & Veerle Baekelandt. (2014). Viral Vector-Based Models of Parkinson’s Disease. Current topics in behavioral neurosciences. 22. 271–301. 45 indexed citations
16.
Rompuy, Anne‐Sophie Van, Evy Lobbestael, Anke Van der Perren, Chris Van den Haute, & Veerle Baekelandt. (2014). Long-Term Overexpression of Human Wild-Type and T240R Mutant Parkin in Rat Substantia Nigra Induces Progressive Dopaminergic Neurodegeneration. Journal of Neuropathology & Experimental Neurology. 73(2). 159–174. 25 indexed citations
17.
Macchi, Francesca, et al.. (2014). Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice. Neurobiology of Aging. 35(11). 2625–2636. 47 indexed citations
18.
Cunha, Marina Gabriela Monteiro Carvalho Mori da, Diego Vilibaldo Beckmann, Marianne Carlon, et al.. (2013). A Surgical Technique for Homogenous Renal Distribution of Substances in Rats. European Surgical Research. 51(1-2). 58–65. 5 indexed citations
19.
Perren, Anke Van der, Nicolas Casadei, Stijn Stroobants, et al.. (2013). rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Molecular Neurodegeneration. 8(1). 44–44. 144 indexed citations
20.
Vercammen, Linda, Anke Van der Perren, Elisabetta Vaudano, et al.. (2006). Parkin Protects against Neurotoxicity in the 6-Hydroxydopamine Rat Model for Parkinson's Disease. Molecular Therapy. 14(5). 716–723. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer A. Steiner Breakdown of academic impact, for papers by Kathleen A. Maguire‐Zeiss Breakdown of academic impact, for papers by Annick Prigent Breakdown of academic impact, for papers by Ayşe Ulusoy Breakdown of academic impact, for papers by Ashley S. Harms Breakdown of academic impact, for papers by Valerie Joers Breakdown of academic impact, for papers by James B. Koprich Breakdown of academic impact, for papers by Etty Cortés Breakdown of academic impact, for papers by Henrik Wilms Breakdown of academic impact, for papers by Svetlana Vidensky
Rankless by CCL
2026